| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012267985 |
| P356 | DOI | 10.1007/S00280-016-3110-Y |
| P698 | PubMed publication ID | 27535835 |
| P50 | author | Woo-Yoon Park | Q73706620 |
| P2093 | author name string | Jae-Ran Yu | |
| Zhengzhe An | |||
| Prabakaran D Subramanian | |||
| P2860 | cites work | Regulation of apoptosis by the Ft1 protein, a new modulator of protein kinase B/Akt | Q24306562 |
| An FTS/Hook/p107(FHIP) complex interacts with and promotes endosomal clustering by the homotypic vacuolar protein sorting complex | Q24313607 | ||
| EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment | Q24338426 | ||
| Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross-linking agent cisplatin | Q33200727 | ||
| Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives | Q33211152 | ||
| Ft1, a novel gene related to ubiquitin-conjugating enzymes, is deleted in the Fused toes mouse mutation | Q34447767 | ||
| Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group study | Q34850394 | ||
| Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study | Q35154219 | ||
| A phase II trial of erlotinib in recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study | Q37294922 | ||
| Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma | Q37316834 | ||
| Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function | Q37676970 | ||
| Cisplatin resistance: preclinical findings and clinical implications | Q37774468 | ||
| Prognostic cell biological markers in cervical cancer patients primarily treated with (chemo)radiation: a systematic review | Q37825064 | ||
| Epidermal growth factor receptor as a biomarker for cervical cancer | Q37843137 | ||
| EGFR inhibitor enhances cisplatin sensitivity of oral squamous cell carcinoma cell lines | Q38847029 | ||
| FTS is responsible for radiation-induced nuclear phosphorylation of EGFR and repair of DNA damage in cervical cancer cells. | Q38963347 | ||
| EGF-induced expression of Fused Toes Homolog (FTS) facilitates epithelial-mesenchymal transition and promotes cell migration in ME180 cervical cancer cells | Q39284745 | ||
| Threonine 2609 phosphorylation of the DNA-dependent protein kinase is a critical prerequisite for epidermal growth factor receptor-mediated radiation resistance | Q39290667 | ||
| Fused Toes Homolog modulates radiation cytotoxicity in uterine cervical cancer cells. | Q39572618 | ||
| FTS (fused toes homolog) a novel oncoprotein involved in uterine cervical carcinogenesis and a potential diagnostic marker for cervical cancer | Q39644388 | ||
| Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity | Q40396981 | ||
| Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase | Q40401323 | ||
| Enhanced sensitivity to the HER1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib hydrochloride in chemotherapy-resistant tumor cell lines. | Q40451017 | ||
| Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells | Q40554483 | ||
| DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin | Q40680519 | ||
| Cisplatin-induced activation of the EGF receptor | Q42807345 | ||
| cIAP2 Upregulated by E6 Oncoprotein via Epidermal Growth Factor Receptor/Phosphatidylinositol 3-Kinase/AKT Pathway Confers Resistance to Cisplatin in Human Papillomavirus 16/18–Infected Lung Cancer | Q43777713 | ||
| EGCG suppresses Fused Toes Homolog protein through p53 in cervical cancer cells. | Q50472183 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 753-762 | |
| P577 | publication date | 2016-08-17 | |
| P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
| P1476 | title | Silencing of fused toes homolog enhances cisplatin sensitivity in cervical cancer cells by inhibiting epidermal growth factor receptor-mediated repair of DNA damage | |
| P478 | volume | 78 |
Search more.